AI assistant
Sending…
Twist Bioscience Corp — Director's Dealing 2022
Dec 21, 2022
31873_dirs_2022-12-21_ad684343-df0a-47f9-8df6-44e3da66cc79.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2022-12-19
Reporting Person: Finn Patrick John (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-12-19 | Common Stock | A | 35484 | — | Acquired | 72773 | Direct |
Footnotes
F1: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of December 19, 2022 for a total vesting period of 48
months, subject to the Reporting Person's continuous service through each vesting date.
More from Twist Bioscience Corp
Capital/Financing Update
2026
Jun 18
Earnings Release
2026
May 4
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 17
Interim / Quarterly Report
2026
Feb 26
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25